Get the Stockscreener App
16.23
0.06%
-0.010
Pre-market:
16.26
0.03
+0.18%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $16.23, with a volume of 44.14M.
It is down -0.06% in the last 24 hours and up +6.15% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
See More
Previous Close:
$16.24
Open:
$16.44
24h Volume:
44.14M
Relative Volume:
1.19
Market Cap:
$31.11B
Revenue:
$15.14B
Net Income/Loss:
$1.42B
P/E Ratio:
22.05
EPS:
0.7361
Net Cash Flow:
$1.63B
1W Performance:
-2.93%
1M Performance:
+6.15%
6M Performance:
-32.88%
1Y Performance:
-31.58%
1-Day Range:
$16.10
$16.61
1-Week Range:
$15.94
$17.24
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
16.23 | 31.11B | 15.14B | 1.42B | 1.63B | 0.7361 |
|
PG
Procter Gamble Co
|
146.99 | 340.74B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
KMB
Kimberly Clark Corp
|
103.25 | 34.40B | 18.08B | 1.81B | 2.10B | 5.904 |
|
CL
Colgate Palmolive Co
|
79.33 | 63.53B | 20.10B | 3.04B | 3.44B | 3.569 |
|
CLX
Clorox Co
|
100.14 | 12.35B | 7.10B | 824.00M | 761.00M | 6.5244 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Nomura Asset Management Co. Ltd. Sells 1,197,203 Shares of Kenvue Inc. $KVUE - MarketBeat
Rothschild Investment LLC Decreases Position in Kenvue Inc. $KVUE - MarketBeat
Intech Investment Management LLC Buys 87,885 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Bought by Clal Insurance Enterprises Holdings Ltd - MarketBeat
How risky is Kenvue Inc. stock compared to peersTrade Analysis Report & Growth Oriented Trade Recommendations - newser.com
Is Kenvue Inc. stock positioned for digital growth eraPortfolio Return Report & Consistent Profit Trade Alerts - newser.com
Kenvue Inc. $KVUE Shares Purchased by Cetera Investment Advisers - MarketBeat
Why Kenvue Inc. stock is favored by top institutionsCPI Data & Expert Approved Momentum Ideas - newser.com
What dividend safety score for Kenvue Inc. stockTrade Volume Summary & AI Powered Buy and Sell Recommendations - newser.com
Why institutional investors increase stakes in Kenvue Inc. stockJuly 2025 PreEarnings & Verified Technical Trade Signals - newser.com
Is Kenvue Inc. stock a buy during volatile marketsTrade Signal Summary & Daily Profit Focused Stock Screening - newser.com
Why analysts maintain buy rating on Kenvue Inc. stockTrade Ideas & Stepwise Trade Signal Implementation - newser.com
Tick level data insight on Kenvue Inc. volatilityTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Is now a turning point for Kenvue Inc.Portfolio Risk Report & Intraday High Probability Alerts - newser.com
Appeals court hints it may reinstate Tylenol autism cases - Seeking Alpha
15,712 Shares in Kenvue Inc. $KVUE Purchased by Vise Technologies Inc. - MarketBeat
Hold Rating on Kenvue, Inc. Amidst Legal Uncertainties and Litigation Risks - TipRanks
27,500 Shares in Kenvue Inc. $KVUE Acquired by Itau Unibanco Holding S.A. - MarketBeat
Kenvue, Inc.: Hold Rating Amid Legal Uncertainties and Market Volatility - TipRanks
Kenvue (NYSE:KVUE) Russell 1000 Index Maps Health Expansion - Kalkine Media
More Pain Ahead For Kenvue Stock? Court Signals Tylenol Autism Cases May Return Amid Retail Bearishness - MSN
Tylenol Maker Kenvue Shares Fall as US Court Weighs Reviving Autism Lawsuits - Bloomberg.com
How Kenvue Inc. stock reacts to global recession fearsPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
Judges question dismissal of private Tylenol lawsuits; Kenvue shares fall - MarketScreener
Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Dispute - inkl
Federal appeals court to consider reinstating Kenvue's Tylenol and autism cases - Seeking Alpha
Westpac Banking Corp Sells 41,252 Shares of Kenvue Inc. $KVUE - MarketBeat
US appeals court to weigh reviving cases over Tylenol and autism - MarketScreener
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Purchases 32,417 Shares of Kenvue Inc. $KVUE - MarketBeat
Judge Denies Texas Bid for Bar on Tylenol Marketing - The Business of Fashion
Kenvue Inc. $KVUE Holdings Lifted by Candriam S.C.A. - MarketBeat
Empower Advisory Group LLC Boosts Position in Kenvue Inc. $KVUE - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys 44,173 Shares of Kenvue Inc. $KVUE - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Purchases 102,683 Shares of Kenvue Inc. $KVUE - MarketBeat
Alberta Investment Management Corp Has $18.71 Million Position in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Buys Tylenol Producer Kenvue for $40 Billion – The Stillman Exchange - Seton Hall University
Judge denies AG Paxton’s bid for bar on Tylenol marketing in state - Dallas News
Why analysts raise outlook for Kenvue Inc. (J4D) stockTrade Ideas & Scalable Portfolio Growth Methods - newser.com
Why Kenvue Inc. stock is a value investor pickJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
How institutional ownership impacts Kenvue Inc. stockQuarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
Can trapped investors hope for a rebound in Kenvue Inc.Weekly Earnings Recap & Accurate Intraday Trading Signals - newser.com
Predicting Kenvue Inc. trend using moving averagesChart Signals & Safe Entry Momentum Tips - newser.com
Kenvue Inc. $KVUE Stock Holdings Lessened by Massachusetts Financial Services Co. MA - MarketBeat
Kenvue Inc. $KVUE Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Will Kenvue Inc. stock split again soonJuly 2025 Final Week & Accurate Buy Signal Alerts - newser.com
How Kenvue Inc. stock performs in weak economyJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Kenvue Inc. (NYSE:KVUE) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Will Kenvue Inc. stock hit analyst forecasts2025 Institutional Moves & High Yield Stock Recommendations - newser.com
Will Kenvue Inc. stock outperform small cap peersTrade Signal Summary & High Accuracy Trade Alerts - newser.com
Combining price and volume data for Kenvue Inc.July 2025 Momentum & Consistent Profit Alerts - newser.com
Will Kenvue Inc. stock outperform tech sector in 2025Portfolio Return Summary & Long-Term Capital Growth Ideas - newser.com
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):